n-methylaspartate has been researched along with Anxiety Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenze, EJ; Rodebaugh, TL | 1 |
| Murphy, CL; Nandhra, HS; Sule, A | 1 |
| Altemus, M; Anderson, P; Andersson, E; Cukor, J; Davis, M; de Kleine, RA; Difede, J; Dunlop, BW; Farrell, LJ; Fernández de la Cruz, L; Finck, C; Frumento, P; Geffken, GR; Geller, D; Gerardi, M; Golfels, F; Goodman, WK; Guastella, AJ; Gutner, C; Hendriks, GJ; Heyman, I; Hofmann, SG; Jovanovic, T; Kushner, MG; Lee, FS; Lenze, EJ; Levinson, CA; Lewin, AB; Mataix-Cols, D; McConnell, H; McNamara, JP; Monzani, B; Murphy, TK; Norrholm, S; Otto, MW; Pérez-Vigil, A; Plag, J; Pollack, MH; Ressler, KJ; Rodebaugh, TL; Rosenfield, D; Rothbaum, BO; Rück, C; Scheeringa, MS; Siewert-Siegmund, A; Smits, JAJ; Storch, EA; Ströhle, A; Tart, CD; Thuras, P; Tolin, DF; van Minnen, A; Waters, AM; Weems, CF; Wilhelm, S; Wyka, K | 1 |
| Borelli, KG; Brandão, ML; dos Santos, JM; Gárgaro, AC | 1 |
| Howells, FM; Russell, VA | 1 |
3 review(s) available for n-methylaspartate and Anxiety Disorders
| Article | Year |
|---|---|
Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
Topics: Animals; Antimetabolites; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Humans; Implosive Therapy; N-Methylaspartate; Treatment Outcome | 2013 |
Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Cognition; Drug Design; Humans; Memory; Molecular Targeted Therapy; N-Methylaspartate; Receptors, Adrenergic, beta | 2013 |
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Topics: Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Drug Synergism; Excitatory Amino Acid Agonists; Humans; Implosive Therapy; N-Methylaspartate; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Stress Disorders, Post-Traumatic | 2017 |
2 other study(ies) available for n-methylaspartate and Anxiety Disorders
| Article | Year |
|---|---|
Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Denervation; Disease Models, Animal; Excitatory Amino Acid Agonists; Fear; Learning; Male; N-Methylaspartate; Neural Pathways; Neurons; Neurotoxins; Pons; Raphe Nuclei; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Reflex, Startle; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2005 |
Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Topics: Animals; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Disease Models, Animal; Endocytosis; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; N-Methylaspartate; Norepinephrine; Organ Culture Techniques; Presynaptic Terminals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Species Specificity; Synaptic Transmission | 2008 |